Collectively, these data support the view that 9c exerts potent inhibitory effects on the proliferation, cell cycle, and other malignant processes of NSCLC by regulating the p53 signaling pathway and PI3K-AKT-mTOR signaling pathway. The gene discussed is AKT1; the disease is non-small cell lung carcinoma.